Estrogen receptors (ERs), ERa and ERb, belong to a group of transcription factors that, upon ligand binding, regulate gene expression by binding to specific DNA regions in chromatin as dimers. In this article, we applied the sequential chromatin immunoprecipitation assay (Re-ChIP) to study the simultaneous presence of ERa and ERb on various DNA-binding regions in intact chromatin. ERa/b heterodimers were isolated by precipitation with anti-ERb antibody followed by anti-ERa antibody from a stable MCF-7-derived cell line that expresses endogenous ERa and an inducible version of ERb. The Re-ChIP method was first validated based on the detection of ERa/b heterodimers bound to a promoter region of the pS2 gene known to bind both ERa and ERb. We next examined 12 ER-binding sites using Re-ChIP assays for ERa/b heterodimer recruitment. Our results confirmed the recruitment of ERa/b heterodimers to all these regions. This study represents the first demonstration of binding of ERa/b heterodimers to various DNA-binding regions in intact chromatin.
Introduction
Estrogen receptors (ERs), ERa and ERb, mediators of the biological actions of estrogens, belong to the nuclear receptor protein family. In the classical model of estrogen action, upon ligand binding, the receptor dimerizes, and binds to DNA, followed by recruitment of co-regulatory proteins and transcriptional regulation of target genes. ERa and ERb are highly homologous, displaying 96 and 58% homology in their DNA-and ligand-binding domains (LBD) respectively. The region that is responsible for receptor dimerization lies within the LBD (Dahlman-Wright et al. 2006) . Although ERa and ERb are widely expressed throughout the body, they exhibit distinct expression patterns in a variety of tissues. ERa is expressed primarily in the uterus, kidney, and liver, whereas ERb is highly expressed in the prostate, lung, bladder, and central nervous system (Matthews et al. 2006) .
The fact that there are two ERs suggests that heterodimerization (a/b) could play a role in estrogen signaling. The formation of ERa/b heterodimers has been demonstrated using techniques such as glutathione-S-transferase (GST) pull-down assays (Pace et al. 1997 , Pettersson et al. 1997 , Ogawa et al. 1998 ) and gel shift assays (Cowley et al. 1997 , Tremblay et al. 1999 . The chromatin immunoprecipitation (ChIP) assay is a powerful tool to study protein:DNA interactions in their native chromatin context (Collas & Dahl 2008) . Several recent studies using ChIP assays have explored the binding of ERa and ERb to DNA in intact chromatin in MCF-7 cells (Carroll et al. 2006 , Liu et al. 2008 . However, the association of ERa/b heterodimers to DNA was not investigated in these studies. Using sequential Chip with two antibodies (Re-ChIP), the simultaneous binding of two proteins to the same DNAbinding region can be demonstrated in the context of intact chromatin (Kouskouti & Talianidis 2005) .
In this article, we describe our studies of the binding of ERa/b heterodimers to various DNA-binding regions in intact chromatin, applying the Re-ChIP method to a stable MCF7-derived cell line that expresses endogenous ERa and an inducible version of ERb.
Materials and methods
Generation of tetracycline-inducible stable cell lines MCF-7 Tet-Off cells were purchased from Clontech and maintained in DMEM/F-12 supplemented with 10% (v/v) fetal bovine serum (FBS) and 100 mg/ml G418 (Invitrogen). The cells were transfected with either the parental plasmid (pBI-EGFP) to generate a mock cell line or a plasmid (pBI-EGFP-ERb) expressing a flag-tagged human ERb using the Lipofectamine 2000 reagent (Invitrogen). Cells were selected in the presence of 5 mg/ml blasticidin for 10 days. ERb protein levels were determined by western blot analysis. In order to confirm the functionality of the ERb protein, we examined its effect on cell proliferation.
We evaluated the cell cycle distribution by fluorescence activated cell sorter analysis (FACS) in both MCF-7 mock and MCF-7 ERb expressing cells after 72-h stimulation with E 2 . The FACS analysis revealed a decrease in the percentage of cells in the S phase in MCF-7 ERb cells, 12% compared with 18% in MCF-7 mock cells (data not shown). This finding is in line with previously published data, where overexpression of ERb inhibited the proliferation of breast cancer cells (Chang et al. 2006 , Williams et al. 2008 .
RNA purification and quantification of mRNA levels
To assay ERa and ERb mRNA levels, MCF-7 ERb and MCF-7 mock cells were seeded in six-well plates and grown in the absence of tetracycline (Ktet, CERb) for 4 days. To assay mRNA levels of ER target genes, MCF-7 ERb and MCF-7 mock cells were seeded in six-well plates and grown in 5% FBS dextran-coated charcoal-treated DMEM phenol red free media in the absence of tetracycline (Ktet, CERb) for 2 days, followed by incubation with 10 nM E 2 for 24 h. Total RNA were purified using the RNeasy Mini Kit (Qiagen). Two microgram total RNA from each well was reverse transcribed into cDNA using TaqMan Reverse Transcription Reagents (Applied Biosystems) with random hexamer primers. Real-time (RT) PCR assays were conducted using the Applied Biosystems 7500 fast RT PCR system with SYBR green master mix RT-PCR reagent (Applied Biosystems, Stockholm, Sweden). All RT-PCRs were performed in duplicate. Acidic ribosomal phosphoprotein PO (36B4) was used as internal control gene (Akamine et al. 2007) . The sequences of the primers are listed in Table 1 .
Western blot analysis of ERa and ERb protein levels MCF-7 ERb and MCF-7 mock cells were seeded in 150 mm dishes and grown in the absence of tetracycline (Ktet, CERb) for 4 days. Total cell extracts were prepared as previously described (Zhao et al. 2007) . Aliquots corresponding to 40 mg cell extract and 1-10 ng human recombinant ERa and ERb (Invitrogen) were separated by SDS/PAGE. For quantification of ERb and ERa protein levels, we used the anti-ERb rabbit polyclonal antibody LBD, developed in our laboratory (Omoto et al. 2001 ) and the anti-ERa rabbit polyclonal antibody HC-20 (Santa Cruz, Stockholm, Sweden). Protein bands were quantified with densitometry using Scion Image Software, Maryland, USA.
Chromatin immunoprecipitation/ re-immunoprecipitation MCF-7 ERb and MCF-7 mock cells were seeded in 150 mm dishes and grown in the absence of tetracycline (Ktet, CERb) for 4 days. Cells were treated with 10 nM E 2 for 45 min and ChIP was performed as previously described (Matthews et al. 2006 , Liu et al. 2008 . The anti-ERb rabbit polyclonal antibody LBD (Omoto et al. 2001 ) was used to perform ChIP for ERb and the rabbit polyclonal anti-ERa antibody HC-20 (Santa Cruz) was used for ERa ChIP. The rabbit polyclonal anti-RNA polymerase II antibody H-224 (Santa Cruz) was used for RNA polymerase II ChIP. Normal rabbit IgG was used for the determination of non-specific binding. For Re-ChIP, ChIP was performed with the anti-ERb LBD antibody or the anti-ERa antibody HC-20. Beads from the first cycle of ChIP were incubated with an equal volume of 10 nM dithiothreitol at 37 8C for 30 min, centrifuged at 16 000 g for 1 min to elute DNA-bound proteins. The elution was repeated twice. The final elute was diluted 1:15 in lysis buffer containing a protease inhibitor cocktail (Roche) and re-immunoprecipitated with the anti-ERa HC-20 antibody, the antiPol II H-224 antibody, or normal rabbit IgG. The final pellet was processed for western blotting (ChIP protein) or, after reverse cross-linking, for PCR or RT PCR (ChIP DNA). Table 1 Primer pairs employed to quantify mRNA levels of estrogen receptors (ERa, ERb), the internal control gene, acidic ribosomal phosphoprotein PO (36B4), as well as of some selected genes
Forward
Reverse
TTCCACACCTGCCTCATGGT GCGGTCCACAGCAATTGC Z PAPOUTSI and others . Binding of ERa/b heterodimers to chromatin Re-ChIP followed by western blotting, PCR or RT PCR Total ChIP protein was eluted from beads and separated by SDS/PAGE followed by detection with the anti-flag M5 monoclonal antibody (Sigma). Equal amounts of PCR product after amplification with pS2 primers (Table 2) were analyzed by gel electrophoresis and visualized by ethidium bromide staining. Immunoprecipitated DNA was amplified by RT PCR using Platinum SYBR green quantitative PCR supermix uracil DNA glycosylase (Invitrogen). The primer sequences for the 14 genes that were investigated are given in Table 2 .
Results
The MCF-7 ERb cell line expresses similar levels of ERa and ERb
A stable cell line, MCF-7 ERb, that expresses an inducible version of ERb fused to a flag tag, was used in all experiments. The MCF-7 mock cell line, a clone of MCF-7 stably transfected with the empty vector, was used as a negative control for ERb expression. The cell lines express endogenous ERa. Initially, we measured the mRNA levels of both ERa and ERb at conditions similar to those of the ChIP and Re-ChIP experiments.
As shown in Fig. 1A , the MCF-7 mock cell line and the MCF-7 ERb cell line express equal amounts of ERa mRNA levels. In the MCF-7 ERb cell line, ERb mRNA levels were similar to those of ERa, while the ERb mRNA levels were undetectable in the MCF-7 mock cell line. Protein levels of ERa and ERb were quantified, under the same conditions, by western blot analysis using purified ERa and ERb proteins as standards. As shown in Fig. 1B , high levels of ERb protein were observed in the MCF-7 ERb cell line, whereas no expression of ERb was detected in the MCF-7 mock cell line. In Fig. 1C Fig. 2A) . Additionally, binding to the pS2 promoter region, after sequential immunoprecipitation with ERb and ERa antibodies, was confirmed using RT PCR. As shown in Fig. 2B , a significant recruitment of ERa to the pS2 promoter was observed in the MCF-7 mock cell line, while ERa, and ERb, as well as ERa/b heterodimers, were recruited to the pS2 promoter in the MCF-7 ERb cell line. Our group has recently identified genome-wide ERaand ERb-binding regions in the MCF-7 ERb cell line by the ChIP-on-chip assay (unpublished data). Based on this information, 12 regions (each labeled by the closest gene in Fig. 3 ) that were identified as binding regions for both ERa and ERb with similar signal intensity in the ChIP-on-chip analysis (ratio of ChIP sample to input sample) were selected for further studies of the Table 2 Primer pairs for amplification of chromatin immunoprecipitation assay (ChIP) and Re-ChIP enriched regions
Forward
CCT CCC GCC AGG GTA AAT AC CCG GCC ATC TCT CAC TAT GAA NBPF1 AGC GGC ATC CCC AGT GT AGG GTG CCT GGA GCT TAA GC NBPF4 GGC TGC AGA GGT GGG TAT GA GCC CCA TTG GCA GAT CAC T VANGL1 GGC TTG GCT TGT GCT ACG A AGT TAG GGT GGC AGC AAC CTT NOTCH2 CCA TTC TTG CTC TTG CCT TAG AG GCT TGT GGC CAT GTT TTG C NOTCH2NL CAG CAG GTC AGA TTC CAT CGA TGA GAG CCT GTT TTC TTG AGC AT BCL9 TTG ACA GAA GCC CTG GAG ATG GCC TGC CAG GTT TCA GGA A NBPF15
CTT GTT TTA GCT CAT CTG TCC ATC A GGG TGA AAA GTC AGC CGT TTA T PRUNE GAG AGC AAA AAG CCA AGG TTA CA ACA GCC TCG GCA AAT ATC TTC T PBX1 TTC CTG CCG GCT TTG TGG GCC TGC CGT GAC CTC TTC TA NR5A2 AAG CAA AGA GAT GAT GGA TGT AAC TC CCT TTT TCC TCC CCA GTT GTG ADORA1
GAT GGA TGG GAA CAC ATT GGT TGG TGG CGG AGC ACA AA CAPN2 CTG GCA TCT GCC TAC AGC AA GTG TCA TTG TGC CCC AAC AG binding of ERa/b heterodimers to DNA. Regions from the pS2 promoter and the 18S gene, which serve as ER-bound positive control and ER-bound negative control respectively were also included in the experiments. The binding of ERa and ERb to these DNA-binding regions was confirmed using ChIP followed by RT PCR (Fig. 3) . All the binding sites exhibited similar fold enrichment for both ERs. There was no recruitment of any ER to a region of the 18S gene in the MCF-7 ERb cell line. In the MCF-7 mock cell line, with no expression of ERb, there was no detectable recruitment of ERb to any of the binding sites tested, while the recruitment of ERa was similar to that in the MCF-7 ERb cell line (data not shown).
To study the binding of ERa/b heterodimers to these regions in the context of intact chromatin, we performed Re-ChIP experiments. Re-ChIP was performed with the anti-ERb antibody followed by the antiERa antibody and precipitated DNA was analyzed using RT PCR. In the MCF-7 ERb cell line, all analyzed binding regions from the pS2 (trefoil factor 1), neuroblastoma breakpoint family, member 4 (NBPF4), NOTCH Drosophila homolog 2 (NOTCH2), NOTCH Drosophila homolog 2 N-terminal like (NOTCH2NL), NBPF15, PRUNE (Drosophila h-prune homolog), B-cell chronic lymphoblastic leukemia/lymphoma 9 (BCL9), pre-B-cell leukemia homeobox 1 (PBX1), nuclear receptor subfamily 5, group A, member 2 (NR5A2), adenosine A1 receptor (ADORA1), calpain 2 (CAPN2), NBPF1, and Van Gogh-like 1 (VANGL1) genes exhibited significant fold enrichment of ERa/ERb heterodimers, whereas there was no enrichment to the analyzed region of 18S (Fig. 4) . 
Recruitment of RNA polymerase II to ERa/b-bound DNA regions
To investigate the effect of ERb on transcriptional regulation and in particular on the recruitment of RNA polymerase II, we performed ChIP experiments using an anti-PolII antibody. As shown in Fig. 5A , PolII is recruited to the pS2 promoter in both the MCF-7 mock and the MCF-7 ERb cell lines. However, the PolII recruitment is significantly decreased by ERb expression in the MCF-7 ERb cell line (Fig. 5A) . Re-ChIP assays (ERb/PolII, ERa/PolII and ERb/ERa) were used to assay co-recruitment of ERs and RNA polymerase II to the pS2 promoter. As shown in Fig. 5B , a significant co-recruitment of ERa and PolII to the pS2 promoter was observed in the MCF-7 mock cell line, while, as expected, there was no co-recruitment of ERb and PolII or ERa and ERb in this cell line. In the MCF-7 ERb cell line, significant recruitment to the pS2 promoter was observed for all three Re-ChIP assays, suggesting that PolII co-exists with ERa and ERb on this binding site.
Estrogen treatment affects expression of genes close to ERa/b-bound DNA regions
To assay whether the presence of ERb affects the expression of ERa-mediated transcription, we compared the mRNA levels of seven selected genes in the MCF-7 ERb cell line versus the MCF-7 mock cell line in response to E 2 treatment and increased expression of all tested genes, following E 2 treatment, was observed in the MCF-7 mock cell line (Fig. 6) . Interestingly, in the presence of ERb, the expression of pS2, ADORA1, NBPF1, and NBPF4 was decreased, the expression of PRUNE and NOTCH2 not changed while the expression of BCL9 was increased. 
Discussion
In this study, we report the identification of ERa/b heterodimer-binding DNA regions in MCF-7 ERb cells that express an inducible version of ERb and endogenous ERa, using a Re-ChIP assay. As a negative control, we used a mock MCF-7 cell line. Although the formation of ERa/b heterodimers has been previously demonstrated using GST-pull down and gel-shift assays (Pace et al. 1997 , Pettersson et al. 1997 , the exact role of ERa/b heterodimers in estrogen signaling remains largely unknown. However, it is assumed that in cell types, where the two receptor subtypes are co-expressed, the formation of ERa/b heterodimers plays an important role in E 2 signaling (Matthews et al. 2006) . Recent studies have explored the ERa-and ERbbinding sites for whole genomes or for specific chromosomes (Carroll et al. 2006 , Liu et al. 2008 ; following up on these studies, we studied ERa/b heterodimers in a cell system where both ERa and ERb are expressed. It has been observed previously that the extent of formation of ERa/b heterodimers in a system, with both ERs are present, depends upon the relative amount of contributing receptors (Li et al. 2004) . Under conditions of co expression of ERs at similar levels, we applied a Re-ChIP assay, followed by RT PCR, to characterize in a quantitative manner the recruitment of ERa/b heterodimers to various DNAbinding regions in intact chromatin. We detected, by western blotting the ERb protein only in the ERb-ERa and not in the ERb-IgG immunoprecipitated samples after Re-ChIP assay ( Fig. 2A) . We confirmed the presence of ERa/b heterodimers on the pS2 promoter, a well-characterized promoter to which both ERa and ERb bound in the MCF-7 ERb cell line (Zhao et al. 2007) . As shown in Fig. 2 , amplification of the pS2 promoter was only detected in ERb-ERa immunoprecipitated fractions from the MCF-7 ERb cell line Previously, Monroe et al. (2005) showed binding of ERa/b heterodimers to chromatin in a modified osteoblast cell line by amplifying ER-binding region of two genes, RBBP1 and DHCR7.
In order to study the simultaneous presence of ERa/b heterodimers on various binding sites in intact chromatin, we queried ER-binding sites recently mapped by the ChIP-on-chip assay (data not shown) and randomly selected 12 DNA regions, which showed similar signal intensity (ratio of ChIP sample to input sample) in the ChIP-on-chip assay for ERa and ERb. Notably, eight binding sites are located within genes (NBPF1, NBPF4, VANGL1, NOTCH2, NOTCH2NL, BCL9, NBPF15, and PBX1), and the residual four are located in the promoter regions (NR5A2, ADORA1, CAPN2, and PRUNE).
To confirm the recruitment of both ERa and ERb to the regions identified by the ChIP on chip experiment, we performed ChIP assays using ERa or ERb antibodies. All the binding sites tested exhibited significant recruitment of ERa and ERb and the level of recruitment was similar for both receptors. Next, we examined the binding of ERa/b heterodimers to the selected DNA regions using a Re-ChIP assay. In the MCF-7 ERb cell line, all the investigated DNA-binding regions Z PAPOUTSI and others . Binding of ERa/b heterodimers to chromatin showed significant recruitment of heterodimers. However, it is notable that different binding sites exhibit different fold enrichment of ERa/b heterodimers. This could be attributed to variations in affinity of heterodimers to various ER-binding sites depending upon the sequence of the binding regions. In a preliminary analysis, using the CONSITE program (Sandelin et al. 2004 ) and setting TF-score cut-off at 85%, we found that all of the selected binding sites contained half-ERE motif, 70% contained AP1-motif (pS2, NOTCH2, NOTCH2NL, PRUNE, BCL9, NR5A2, ADORA1, NBPF1, and VANGL1), but only 23% contained full-ERE (pS2, NR5A2, and ADORA1). However, the detailed dissection of the mechanism of heterodimers' recruitment needs a larger number of such identified regions and a systematic binding motifs enrichment analysis with strict background control. Furthermore, our data showed that the ratio of enrichment in the ERa/b Re-ChIP assay versus the enrichment in the ERa and ERb ChIP assays varied. For example, for genes such as NBPF4, NOTCH2, NBPF15, and PRUNE, this ratio is high, suggesting that heterodimer recruitment may play a more significant role in the transcriptional regulation of these genes. Our results also showed that overall there is less recruitment of heterodimers compared with ERa or ERb alone. This may be due to the recovery being less after two rounds of ChIP (Re-Chip assay) compared with the single ChIP assay. Additionally, previous kinetic studies have revealed that heterodimers exhibit low binding affinity (Jisa & Jungbauer 2003) .
Previous work has shown that the presence of ERb can affect ERa's transcriptional activity (Chang et al. 2006) . To verify this in our cell system, we evaluated the mRNA levels of some selected genes after E 2 treatment. Our data showed that mRNA levels of genes that are implicated in cell proliferation, like pS2, and Adora1 are down-regulated, when ERb is expressed (Ribieras et al. 1998 , Mirza et al. 2005 . The decrease of pS2 mRNA levels in the MCF-7 ERb cells is in accordance with the decrease of PolII recruitment to the pS2 promoter in the same cell line as compared with MCF-7 mock cells. The mRNA levels of NBPF1 and NBPF4, whose function is not fully explored, are also decreased in the presence of ERb (Vandepoele et al. 2005) . mRNA levels of BCL9, which is participating in the wnt signaling of cell proliferation and development, were up-regulated in the MCF-7 ERb cell line compared with the MCF-7 mock cell line (Willert & Jones 2006) . Finally, the mRNA levels of NOTCH2 and PRUNE were unaffected by the presence of ERb. These genes are both implicated in the aggressiveness of breast neoplasm (Marino & Zollo 2007 , Wang et al. 2008 . Considering that all selected genes exhibit significant ERa/b heterodimer recruitment, our data suggest that ERb may have an activating or inhibitory influence on ERa through heterodimerization. Furthermore, using a Re-ChIP assay and various combinations of ERa, ERb, and PolII antibodies, we showed that PolII co-occupied the same DNA-binding regions as ERa and ERb, consistent with a role of ERa/b heterodimers in transcriptional regulation.
In this study, we report the recruitment of ERa/b heterodimers to various ER-binding DNA regions in an intact cell system, following E 2 treatment. Further experimental data are needed to elucidate the detailed mechanism of formation of ERa/b heterodimers, their function, and the influence of ligands.
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